Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 24

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 24
---
 3-to-5-day period, they are transferred to the uterine cavity.

As a long-standing IVF treatments
provider in Asia-Pacific, NewGenIvf had completed over 4,500 cycles of IVF treatments from 2014 to 2024. For the years ended December 31,
2024 and 2023, the revenue from NewGenIvf’s IVF treatments was US$5,433,375 and US$4,021,696, respectively, representing 100% and
78.3% of its total revenue in the corresponding periods.

IVF Treatments Process

A typical IVF treatment process
mainly includes two stages, the pre-IVF treatment stage and the IVF treatment stage. During the IVF treatment process, NewGenIvf also
provides support services such as nutrition guidance and psychological counselling. The flow chart below shows the stages involved in
a typical IVF treatment process:

At the pre-IVF treatment
stage, clients attend an initial consultation, undergo pre-IVF tests, and undergo treatment for gynaecological and andrological
diseases, if needed. At the initial consultation, a physician reviews the clients’ detailed medical history to collect more
information relating to the potential cause of their infertility. The client then undergoes various pre-IVF tests, which may
include, among other things, blood pressure, hormone level, ultrasound, infectious disease screening, uterine evaluation and male
fertility test. The physician will then design treatment plans based on the client’s medical history and results of the tests.
If the client is satisfied with treatment plan and the test results are acceptable to the physician, the physician will prescribe
medications and start stimulation treatment.

The first step of the cycle
is to boost egg production through injecting synthetic hormones. Over about one week of ovarian stimulation, clients are monitored on
a regular basis with blood test and transvaginal ultrasound. If follicles have reached at least 10 mm in size, an additional antagonist
drug will be added into the daily injection schedule. This is used to prevent ovulation before ovum pickup time. After another few days
of ovarian simulation, if follicle growth is consistent and majority of follicles are around 16 mm to 17 mm, the final injection of a
human chorionic gonadotropin will be administered. The trigger injection is the final step of the stimulation process and is for the maturation
of the